


Spektus Pharma
Pharmaceutical Manufacturing • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 3254 |
| Founded | 2024 |
| Employees | 1-10 |
Key Contact at Spektus Pharma
Zarvaan Merchant
Chief Executive Officer
About Spektus Pharma
Spektus Pharma is a specialty pharmaceutical company focused on developing and delivering value-added medicines in the Central Nervous System (CNS) segment. Our portfolio targets key areas of unmet need in depression, ADHD, and pain, with differentiated therapies designed to improve outcomes across diverse patient populations. At the core of our innovation is Flexitab®, a patented breakable extended-release technology that provides clinically meaningful benefits and supports new label claims. Protected by robust intellectual property, each product is engineered to address today’s commercial challenges while meeting the needs of patients, healthcare providers, and payers. Spektus brings its medicines to market worldwide through regional licensing agreements with leading pharmaceutical partners—ensuring broad global access to innovative therapies that make a measurable difference in patients’ lives.
Spektus Pharma revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Spektus Pharma has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Spektus Pharma has never raised funding before.
Spektus Pharma Tech Stack
Discover the technologies and tools that power Spektus Pharma's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
JavaScript libraries
Tag managers
Miscellaneous
Security
Miscellaneous
Page builders
Analytics
Font scripts
Frequently asked questions
4.8
40,000 users



